Search Results
Results found for "Evaxion Biotech"
Posts (125)
- Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, today Vraniak served as Chief Financial Officer of Evaxion Biotech A/S, an AI enabled immuno-oncology company
- The Hidden Operating Cadence That’s Actually Driving Your Biotech
But here’s the uncomfortable truth: 👉 Your biotech is already running on an operating cadence you didn Operating cadence is the quiet force behind biotech momentum, the rhythm that turns intention into real The Pattern: Your “Accidental Cadence” 👉 Every biotech has a cadence. Many early-stage biotechs show the same pattern: strong scientific progress paired with an operating Strategic Takeaway Your biotech is already running on an operating cadence.
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
Biotech fundraising has undergone a subtle yet significant shift. Clear intellectual property builds confidence on both sides of the biotech fundraising table Why biotech Biotech fundraising rarely fails in the diligence phase itself. In modern biotech fundraising, intellectual property functions as a shortcut. In biotech fundraising, coherence builds trust.
Other Pages (107)
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
GPCR — Scaling Biotech Beyond the Bench Turning scientific excellence into scalable organizations. Our work helps biotech startups, research organizations, and CROs design operating systems that enable Bu Attila Foris 5 days ago The One Reason Why Biotech Startups Fail More Often Than They Should Biotech When complexity grows faster than strategy, biotech companies drift. Biotech fundraising has undergone a subtle yet significant shift.
- Started in medicinal chemistry. Got hooked on ligand design. Dr. Maria Majellaro didn’t plan to run a biotech company. A thesis project, a mentor’s advice, and a leap during the pandemic changed everything. Now she’s leading Celtarys, building custom fluorescent probes, and partnering with Dr. GPCR to support assay development worldwide. Meet Celtarys and learn more about its leading work on ligand-linker-fluorophore chemistry 🚀 ✳️ Listen now: https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ep-168-with-dr.-maria-majellaro-from-celtarys #GPCRcommunity #DrGPCR #FluorescentLigands #GPCRdrugDiscovery #ScientificLeadership #BiotechInnovation | Dr. GPCR Ecosystem
Maria Majellaro didn’t plan to run a biotech company. Maria Majellaro didn’t plan to run a biotech company. Bu Attila Foris 5 days ago The One Reason Why Biotech Startups Fail More Often Than They Should Biotech When complexity grows faster than strategy, biotech companies drift. Biotech fundraising has undergone a subtle yet significant shift.
- 🎧 Why Does GPCR Location Make All the Difference? GPCR location within the cell can change everything: function, pharmacology, and even drug response. In Ep.162 of the Dr.GPCR Podcast, Dr. Gabriele Kockelkoren dives into: 🔬 How GPCR trafficking shapes signaling outcomes 🚀 Career insights from the lab to the broader biotech world This episode is packed with knowledge for scientists, drug hunters, and anyone fascinated by GPCRs! 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast ✅ Tune in today! | Dr. GPCR Ecosystem
into: 🔬 How GPCR trafficking shapes signaling outcomes 🚀 Career insights from the lab to the broader biotech 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast into: 🔬 How GPCR trafficking shapes signaling outcomes 🚀 Career insights from the lab to the broader biotech 🎙️ Listen now https://buff.ly/fYZ1tSq #DrGPCR #GPCR #DrugDiscovery #Pharma #Biotech #SciencePodcast
